Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations
Author(s) -
Mohanad Naji Sahib,
Darwis Darwis,
Peh,
Shaymaa Abdalwahed Abdulameer,
Tan
Publication year - 2012
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s28265
Subject(s) - chemistry , solubility , drug , bioavailability , micelle , pharmacology , zeta potential , inhalation , drug delivery , drug carrier , dosage form , beclometasone dipropionate , ethylene glycol , chromatography , organic chemistry , lung , aqueous solution , medicine , materials science , nanoparticle , nanotechnology , respiratory disease , anesthesia
The local treatment of lung disorders such as asthma and chronic obstructive pulmonary disease via pulmonary drug delivery offers many advantages over oral or intravenous routes of administration. This is because direct deposition of a drug at the diseased site increases local drug concentrations, which improves the pulmonary receptor occupancy and reduces the overall dose required, therefore reducing the side effects that result from high drug doses. From a clinical point of view, although jet nebulizers have been used for aerosol delivery of water-soluble compounds and micronized suspensions, their use with hydrophobic drugs has been inadequate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom